The expanding class of therapies known as GLP-1 receptor activators are revolutionizing blood sugar treatment, but the delivery method is shifting to a key consideration . Previously, these effective medications were prescribed solely in tablet form. However, new transdermal systems are now becoming accessible , causing many patients to wonder whic